COMMUNIQUÉ DE PRESSE publié le 05/12/2023 à 14:30, il y a 11 mois 4 jours Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023 Applied DNA Sciences, Inc. (NASDAQ:APDN) will release its Q4 and full year 2023 financial results on December 7, 2023, after the market close. A conference call for investors will follow to discuss the results Financial Results Conference Call Investor Relations Applied DNA Sciences NASDAQ:APDN
COMMUNIQUÉ DE PRESSE publié le 28/11/2023 à 14:30, il y a 11 mois 11 jours Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
COMMUNIQUÉ DE PRESSE publié le 16/11/2023 à 14:30, il y a 11 mois 23 jours Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
COMMUNIQUÉ DE PRESSE publié le 09/11/2023 à 15:15, il y a 1 année Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
COMMUNIQUÉ DE PRESSE publié le 14/09/2023 à 15:00, il y a 1 année 1 mois Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
COMMUNIQUÉ DE PRESSE publié le 06/09/2023 à 15:00, il y a 1 année 2 mois Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
COMMUNIQUÉ DE PRESSE publié le 29/08/2023 à 15:00, il y a 1 année 2 mois Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit
COMMUNIQUÉ DE PRESSE publié le 23/08/2023 à 15:30, il y a 1 année 2 mois Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production
COMMUNIQUÉ DE PRESSE publié le 10/08/2023 à 22:05, il y a 1 année 2 mois Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
COMMUNIQUÉ DE PRESSE publié le 07/08/2023 à 17:00, il y a 1 année 3 mois Applied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023
Publié le 08/11/2024 à 18:00, il y a 23 heures 30 minutes Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Publié le 08/11/2024 à 18:00, il y a 23 heures 30 minutes Covivio - Information on total number of voting rights and share capital
Publié le 08/11/2024 à 17:52, il y a 23 heures 38 minutes Total number of voting rights and shares making up the share capital at October 31, 2024
Publié le 08/11/2024 à 17:52, il y a 23 heures 38 minutes Capital et droits de vote au 31 octobre 2024
Publié le 08/11/2024 à 17:45, il y a 23 heures 45 minutes CHARGEURS - Voting rights monthly statement as of October 31st, 2024
Publié le 09/11/2024 à 16:30, il y a 1 heure New to the Street Premieres Episode 611 on Bloomberg Television Tonight at 6:30 PM EST, Featuring Zapp Electric Vehicles, OriginClea and PillSafe
Publié le 09/11/2024 à 04:00, il y a 13 heures 30 minutes Freedom Holding Corp. Reports Second Quarter Fiscal Year 2025 Financial Results
Publié le 08/11/2024 à 23:05, il y a 18 heures 25 minutes Murchison Minerals Announces Non-Brokered Private Placement
Publié le 08/11/2024 à 20:15, il y a 21 heures 15 minutes Able View Global Inc. Raises USD$4 Million from Convertible Notes Financing to Propel Growth
Publié le 08/11/2024 à 18:35, il y a 22 heures 55 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 08/11/2024 à 18:20, il y a 23 heures 9 minutes ENCAVIS achieves results in the first three quarters of 2024 below the figures for the same period of the previous year due to unforeseeable events and adjusts guidance for the current financial year
Publié le 08/11/2024 à 18:02, il y a 23 heures 27 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 08/11/2024 à 18:00, il y a 23 heures 30 minutes 2CRSi SA: Provision of the Financial Report
